Go deeper: As WBUR's Priyanka Dayal McCluskey recently reported, the $200 million that BCBS spent on GLP drugs in 2024 was a main driver of why health care premiums for all customers soared this year
There is no confirmed UK launch date
Studies examining receptor binding have shown that Retatrutide demonstrates strong activity at the human GIP receptor while maintaining measurable activity at both GLP-1 and glucagon receptors, creating a balanced activation profile that allows researchers to explore receptor crosstalk and multi-pathway metabolic signaling [2]
We're proud to be Serena's care partner, and even prouder to stand with her as she inspires people nationwide to reach their health goals." This announcement builds on Ro's mission to fight for patients and expand access to GLP-1 treatment through online doctor visits, personalized treatment plans, insurance coordination, education, and ongoing support
High Molecular Complexity: Suitable for studying prolonged receptor interactions and downstream signaling
